Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
1,534 | $15.47 | $23,733 | 320,384 (Indirect Direct) |
View |
| 2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,767 | $15.47 | $73,750 | 931,092 (Indirect Direct) |
View |
| 2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
284 | $15.47 | $4,394 | 5,570 (Direct) |
View |
| 2023-07-20 Sale |
2023-07-24 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
573 | $19.03 | $10,906 | 7,129 (Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,122 | $21.38 | $88,108 | 927,880 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
1,330 | $21.38 | $28,429 | 317,929 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
245 | $21.38 | $5,237 | 6,116 (Direct) |
View |
| 2023-04-21 Sale |
2023-04-25 6:33 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
2,342 | $18.65 | $43,678 | 5,636 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:28 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
3,557 | $19.06 | $67,796 | 94,546 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:28 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,244 | $19.06 | $23,711 | 1,614 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:27 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
12,194 | $19.06 | $232,418 | 536,885 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-28 Other |
2023-08-30 4:15 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
500,000 | $15.87 | 20,157,605 (Indirect) |
View |
| 2023-08-28 Other |
2023-08-30 4:15 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
500,000 | $22.05 | 20,157,605 (Indirect) |
View |
| 2023-08-28 Other |
2023-08-30 4:15 pm |
2018-08-27 2023-08-28 |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
2 | $0 | 20,157,605 (Indirect) |
View |
| 2023-08-14 Exercise |
2023-08-15 4:17 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 12,207 (Direct) |
View |
| 2023-08-14 Exercise |
2023-08-15 4:16 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 345,911 (Direct) |
View |
| 2023-08-14 Exercise |
2023-08-15 4:06 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 983,736 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-20 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,806 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
25,850 | $0 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
3,590 | $13.93 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
25,850 | $0 | 28,722 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
2,872 | $13.93 | 28,722 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
25,850 | $0 | 30,876 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
5,026 | $13.93 | 30,876 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
25,850 | $0 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
3,590 | $13.93 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:04 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 987,858 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:01 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 11,439 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 7:57 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 347,241 (Direct) |
View |
| 2023-04-18 Exercise |
2023-04-20 6:34 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
6,364 | $0 | 20,648 (Direct) |
View |
| 2023-04-04 Option Award |
2023-04-12 7:00 pm |
N/A 2033-04-04 |
ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew Chief Medical Officer |
134,401 | $0 | 134,401 (Direct) |
View |
| 2022-05-19 Other |
2023-04-05 4:31 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
590,744 | $0 | 19,748,348 (Indirect) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
166,037 | $0 | 281,550 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
8,574 | $0 | 281,550 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
265,661 | $0 | 565,756 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
15,720 | $0 | 565,756 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
66,414 | $0 | 75,075 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
2,858 | $0 | 75,075 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
464,907 | $0 | 1,484,059 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
31,440 | $0 | 1,484,059 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
116,226 | $0 | 116,226 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
66,414 | $0 | 66,414 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
166,037 | $0 | 166,037 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
265,661 | $0 | 265,661 (Direct) |
View |